
MediWales
As the independent life science network for Wales, MediWales brings together industry, academia and the clinical community to support the advancement of human life science in Wales and create collaborations and business opportunities for our members

Mironid
A bright future for patients with rare kidney disease Mironid® is developing novel small-molecule therapeutics that directly target the central signalling mechanism that drives ADPKD.
Neil Wilkie
CEO
Nanovery
Our unique platform technology accurately quantifies nucleic acid sequences in your sample with a quick and simple workflow.
Using cutting-edge DNA nanotechnology, we build nanorobotic sensors tailored to your needs, enabling you to reach better outcomes at a fraction of the effort, cost and time.
Jerzy Kozyra
CEO
NIHR Research Delivery Network
Our vision is for the UK to be a global leader in the delivery of high quality research that is inclusive, accessible, and improves health and care.
Our mission is to enable the health and care system to attract, optimise and deliver research across England.
We have two primary purposes:
- support the successful delivery of high quality research, as an active partner in the research system
- increase capacity and capability of the research delivery infrastructure for the future
Tracy Harman
Deputy Director of Strategic DevelopmentEmanuela Mariani
Business Development ManagerRichard Brooks
Senior Business Development ManagerSajni Haria
Senior Business Development ManagerKaren Matthews
Senior Business Development ManagerWilliam Rosenberg
Deputy Medical DirectorLynsey Corless
Gastroenterology and hepatology specialist
Pencil Biosciences

Pracipio
Anticipate, advise and advance - Pracipio helps you achieve your business objectives by applying a team of consultants who have formed a best in class management and strategy consultancy.
Fredrik Elg
Director
Sareum
Sareum is a clinical-stage small molecule company actively involved in developing next-generation kinase inhibitors to treat autoimmune diseases and cancer.
We recognise the crucial role of the TYK/JAK kinase cell signalling family in maintaining a healthy immune system, and our pipeline is primarily focused on this area of scientific and commercial interest.
Tim Mitchell
COO
Scancell
Scancell is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer. We aim to translate our innovation and creativity into increased and durable responses in patients without compromising safety, addressing hard-to-treat cancers.
Mandeep Sehmi
Head of Business Development
Simbec-Orion
We are Simbec-Orion, who for almost five decades, have been delivering clinical trial management services across a wide range of therapeutic indications and phases. A clinical research organisation with a flexible, specialist approach, we strive to become a trusted partner for our clients. Our passion as a CRO is rare diseases and oncology.